YY1 and lung carcinoma: However, future studies are required on the precise regulatory network involved in the downstream molecules of PTEN, YY1, and CDK6 that could contribute to miR-34a-mediated tumor suppression for the clinical treatment of lung cancer in Gejiu and Xuanwei County, Yunnan Province.